Peforelin
Chemical compound
Clinical data | |
---|---|
Trade names | Maprelin |
Other names | Lamprey GnRH-III; H-Pyr-His-Trp-Ser-His-Asp-Trp-Lys-Pro-Gly-NH2; XHWSHDWKPG |
Routes of administration | Injection |
Drug class | GnRH agonist |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.223.356 |
Chemical and physical data | |
Formula | C59H74N18O14 |
Molar mass | 1259.353 g·mol−1 |
3D model (JSmol) |
|
| |
InChI
|
Peforelin (INNTooltip International Nonproprietary Name), or peforelin acetate, sold under the brand name Maprelin, is a gonadotropin-releasing hormone agonist (GnRH agonist) medication which is used in veterinary medicine in Europe and Canada.[1][2][3][4] It is a GnRH analogue and a synthetic peptide, specifically a decapeptide.[1][3][4] The drug was introduced for veterinary use by 2001.[5]
See also
References
- ^ a b [1][dead link]
- ^ "Maprelin XP-10 (Canada) for Animal Use".
- ^ a b Löscher W, Richter A, Potschka H (3 September 2014). Pharmakotherapie bei Haus- und Nutztieren: Begründet von W. Löscher, F.R. Ungemach und R. Kroker. Enke. pp. 435–. ISBN 978-3-8304-1251-9.
- ^ a b Rodriguez-Martinez H (1 April 2010). Control of Pig Reproduction VIII. Nottingham University Press. pp. 190–. ISBN 978-1-907284-53-3.
- ^ http://www.sgau.ru/files/pages/846/14713368000.pdf#page=48 [bare URL PDF]
- v
- t
- e
GnRHTooltip Gonadotropin-releasing hormone and gonadotropins
(incl. analogues)
Agonists | |
---|---|
Antagonists |
|
Preparations |
---|
(indirect)
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
- See also
- GnRH and gonadotropin receptor modulators
- Androgens and antiandrogens
- Estrogens and antiestrogens
- Progestogens and antiprogestogens
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e